Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1-Reference-Cited by-同舟云学术

Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1

Published:2023-08 Issue:8 Volume:18 Page:1055-1069
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Reck Martin^ORCID,Ciuleanu Tudor-Eliade,Lee Jong-Seok,Schenker Michael,Zurawski Bogdan,Kim Sang-We,Mahave Mauricio,Alexandru Aurelia,Peters Solange,Pluzanski Adam,Caro Reyes Bernabe,Linardou Helena,Burgers Jacobus A.,Nishio Makoto,Martinez-Marti Alex,Azuma Koichi,Axelrod Rita,Paz-Ares Luis G.,Ramalingam Suresh S.,Borghaei Hossein,O’Byrne Kenneth J.,Li Li,Bushong Judith,Gupta Ravi G.,Grootendorst Diederik J.,Eccles Laura J.,Brahmer Julie R.

Funder

Bristol-Myers Squibb Company

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference41 articles.

1. Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases;Ali;Curr Oncol,2013

2. Estimating survival in patients with lung cancer and brain metastases: an update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA);Sperduto;JAMA Oncol,2017

3. Abstract 180P: incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19;Cui;J Thorac Oncol,2021

4. Non-small-cell lung cancer with brain metastasis at presentation;Waqar;Clin Lung Cancer,2018

5. Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: analysis from the European FRAME study;Moro-Sibilot;Lung Cancer,2015

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial;European Journal of Cancer;2024-11

2. Brain Metastases as Inaugural Sign of Non-Small Cell Lung Carcinoma: Case Series and Review of Literature;Cancers;2024-09-08

3. The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases;CLIN LUNG CANCER;2024

4. The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases;Clinical Lung Cancer;2024-09

5. The role of immunotherapy in patients with lung cancer and brain metastases: a narrative review of the literature;Monaldi Archives for Chest Disease;2024-07-26